Priser
Platform
Blog
Om os
Download
Versamet Royalties
Versamet Royalties
Nasdaq
0

Markedsdata leveret af TwelveData og Morningstar

Aktiemarkedet kan gå både op og ned. Selvom investeringer i aktier historisk set har givet investorer et positivt afkast på langt sigt, er der ingen garanti for fremtidige afkast. Der er derfor en risiko for, at du ikke får de investerede penge tilbage.

INVESTER I VERSAMET ROYALTIES MED ENDAVU: Køb Versamet Royalties ($VMET) aktier gennem Endavu’s investeringsplatform. Hos Endavu kan du købe og sælge aktier i Versamet Royalties, og handle med aktier, fraktionaler, ETF'er og andre finansielle instrumenter. Endavu tilbyder handel uden kurtage på amerikanske aktier. Endavu tilbyder lav kurtage på tværs af aktier. Handl med over 30.000 forskellige aktier og udenfor markedsåbningstider.

Om

Clínica Baviera, S.A. is a Spain-based medical company specializing in ophthalmology, operating a network of clinics across Spain, Germany, Austria, and Italy. It provides comprehensive diagnosis, treatment, and monitoring for a wide range of visual disorders, including myopia, hyperopia, astigmatism, presbyopia, cataracts, glaucoma, retinal conditions, strabismus, cornea issues, neuro-ophthalmology, tear ducts, oculoplasty, and advanced procedures like LASIK, LASEK, and intraocular lens implants. Additionally, it offers pediatric ophthalmology and plastic surgery services. Founded in 1992 and headquartered in Madrid, the company rebranded from Clínica Oftalmológica Baviera, S.L. to its current name in 2000. As the parent of the Baviera Group, it oversees subsidiaries such as Clinica Baviera Italia Srl and Care Vision Germany GmbH. Acquired by China's Aier Eye Hospital Group in 2017, which holds a 73.23% stake, Clínica Baviera, S.A. employs 1,847 people and plays a key role in the European healthcare facilities and services sector, focusing on specialized eye care.

Information

TickerCBAV
Land
Spanien
Antal medarbejdere1.274
Hjemmesideclinicabaviera.com
SektorSundhed
IndustriDiagnostik og forskning

Udbytter

1,05EUR
'21
1,03EUR
'22
0,8EUR
'23
1,57EUR
'24
1,57EUR
'25
1,57EUR
'26
Ex-udbytte-dato10. jun. 2026
Udbytteafkast2,8%